Dr. Pramod Pinnamaneni, M.D.
What this data tells you about Dr. Pinnamaneni
Dr. Pramod Pinnamaneni is a hospitalist physician in Lufkin, TX, with 14 years in practice. Based on federal Medicare data, Dr. Pinnamaneni performed 15,128 Medicare services across 1,267 unique beneficiaries.
Between the years covered by Open Payments, Dr. Pinnamaneni received a total of $7,506 from 49 pharmaceutical and/or device companies across 209 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hospitalist physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Pinnamaneni is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Contrast dye for imaging (iodine-based) | 3,801 | $0 | $1 |
| Epoetin alfa injection (Retacrit) for anemia | 3,280 | $6 | $45 |
| Dexamethasone injection (steroid) | 1,945 | $0 | $5 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,440 | $1 | $53 |
| Complete blood count (CBC) with differential | 836 | $8 | $65 |
| Blood draw (venipuncture) | 823 | $8 | $25 |
| Office visit, established patient (30-39 min) | 419 | $92 | $350 |
| Injection of additional new drug or substance into vein | 374 | $12 | $80 |
| High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml | 332 | $0 | $1 |
| Administration of chemotherapy into vein, 1 hour or less | 246 | $95 | $550 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 226 | $22 | $205 |
| Administration of chemotherapy into vein, each additional hour | 186 | $22 | $225 |
| Office visit, established patient, complex (40-54 min) | 185 | $132 | $450 |
| Office visit, established patient (20-29 min) | 143 | $63 | $250 |
| Drug injection, under skin or into muscle | 126 | $11 | $65 |
| Irrigation of implanted venous access drug delivery device | 123 | $19 | $250 |
| Administration of additional new drug or substance into vein, 1 hour or less | 120 | $50 | $275 |
| Injection, diphenhydramine hcl, up to 50 mg | 108 | $1 | $15 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 72 | $47 | $250 |
| New patient office visit, complex (60-74 min) | 64 | $163 | $495 |
| Ct scan of chest with contrast | 43 | $71 | $1,141 |
| Advance care planning consultation, first 30 min | 43 | $60 | $145 |
| CT scan of abdomen and pelvis with contrast | 40 | $211 | $1,800 |
| New patient office visit (45-59 min) | 36 | $121 | $475 |
| Blood glucose (sugar) measurement using reagent strip | 26 | $5 | $10 |
| Blood glucose (sugar) test performed by hand-held instrument | 26 | $3 | $10 |
| Nuclear medicine study from skull base to mid-thigh with ct scan | 25 | $1,151 | $7,164 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 23 | $126 | $650 |
| Initial hospital admission, high complexity | 17 | $136 | $490 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (53%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 4% for hospitalist physician in TX.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Pinnamaneni is a mixed practice specialist, with above-average Medicare volume (top 1% in TX), and high industry engagement (low-engagement, top 4%).
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Pinnamaneni experienced with contrast dye for imaging (iodine-based)?
Does Dr. Pinnamaneni receive payments from pharmaceutical companies?
How do Dr. Pinnamaneni's costs compare to other hospitalist physicians in Lufkin?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology